Feb 23, 2026 06:37AM
Feb 19, 2026 01:49PM
Feb 19, 2026 07:07AM
Feb 11, 2026 05:01AM
Feb 4, 2026 06:49AM
Jan 20, 2026 04:38AM
Jan 14, 2026 12:45AM Goldman Sachs Reiterates Buy Rating on Madrigal Pharmaceuticals (MDGL)
Jan 12, 2026 09:32AM
Jan 6, 2026 05:33AM
Dec 19, 2025 08:28AM
Dec 8, 2025 07:32AM
Nov 21, 2025 01:28PM
Nov 20, 2025 04:02AM
Nov 19, 2025 06:05AM Madrigal Pharmaceuticals (MDGL) PT Raised to $640 at Truist Securities, 'We remain buyers'
Nov 13, 2025 05:33AM
Nov 10, 2025 08:02AM
Nov 5, 2025 05:23AM
Nov 5, 2025 04:59AM
Nov 4, 2025 04:08PM
Nov 4, 2025 07:04AM
Nov 3, 2025 06:28AM BofA Securities Upgrades Madrigal Pharmaceuticals (MDGL) to Neutral
Oct 16, 2025 04:19AM
Oct 15, 2025 06:19AM
Oct 14, 2025 04:03PM
Oct 10, 2025 05:29AM
Sep 24, 2025 08:50AM
Sep 12, 2025 06:23AM
Sep 4, 2025 06:14AM H.C. Wainwright Starts Madrigal Pharmaceuticals (MDGL) at Buy
Aug 26, 2025 08:38AM
Aug 22, 2025 07:17AM
Aug 20, 2025 08:54AM
Aug 20, 2025 04:16AM
Aug 19, 2025 04:05PM
Aug 18, 2025 10:59AM
Aug 12, 2025 10:12AM Piper Sandler Reiterates Overweight Rating on Madrigal Pharmaceuticals (MDGL)
Aug 12, 2025 05:22AM
Aug 5, 2025 04:25PM
Aug 5, 2025 07:06AM
Jul 22, 2025 08:00AM
Jul 22, 2025 04:06AM
Jul 16, 2025 02:48PM
Jul 16, 2025 08:02AM Madrigal receives patent allowance for Rezdiffra through 2044
Jul 2, 2025 04:10AM
Jun 20, 2025 06:31AM
Jun 5, 2025 04:26AM
May 13, 2025 04:11PM
May 13, 2025 02:23PM
May 1, 2025 07:13AM
Apr 29, 2025 07:52AM Cantor Fitzgerald Reiterates Neutral Rating on Madrigal Pharmaceuticals (MDGL)
Apr 24, 2025 04:13AM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All